Welcome to our dedicated page for Universal Ins Hldgs SEC filings (Ticker: UVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Universal Insurance Holdings, Inc. (NYSE: UVE) SEC filings page provides access to the company’s regulatory disclosures as a U.S. property and casualty insurance holding company. Universal files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K with the Securities and Exchange Commission, covering its operations in personal residential homeowners lines of business and related insurance services.
Recent Form 8-K filings for Universal Insurance Holdings include announcements of quarterly financial results, share repurchase authorizations and cash dividends on common stock. Earnings-related 8-Ks incorporate press releases that present GAAP and non-GAAP financial measures, such as total revenues, net income available to common stockholders, core revenue, adjusted net income, diluted adjusted earnings per share, adjusted operating income, adjusted book value per share and adjusted return on common equity. These filings also summarize key underwriting metrics, including direct premiums written, net premiums earned, ceded premium ratio, loss ratio, expense ratio and combined ratio.
Other 8-K filings report Board actions authorizing multi-year share repurchase programs and declaring regular and special cash dividends. These documents describe the size and duration of repurchase authorizations, the intention to conduct repurchases in accordance with Rule 10b-18 under the Securities Exchange Act of 1934 and the company’s insider trading policy, and the per-share amounts of declared dividends.
On this page, Stock Titan pairs Universal’s SEC filings with AI-powered summaries that explain the main points of each document in plain language. Users can quickly see what Universal reported in its latest 10-K or 10-Q, how management describes non-GAAP financial measures and key performance indicators, and what material events are disclosed in 8-Ks. The filings feed updates as new documents are posted to EDGAR, helping investors follow Universal’s financial reporting, reinsurance-related disclosures and capital management decisions without reading every line of each filing.
Universal Insurance Holdings, Inc. reported an equity compensation grant to an executive. On December 5, 2025, the company awarded 3,500 restricted stock units (RSUs) tied to its common stock to its Principal Accounting Officer, who is an officer of the company and the sole reporting person on this filing. Each RSU represents a contingent right to receive one share of Universal Insurance common stock.
The RSUs vest in three approximately equal installments on each of the first three anniversaries of the grant date, starting from December 5, 2025, and require the executive to remain employed through each vesting date. This filing is a standard Form 4 disclosure, showing ongoing use of stock-based compensation to align executive interests with shareholders over time.
Universal Insurance Holdings, Inc. executive transaction: Executive Chairman and Director Sean P. Downes reported selling 20,000 shares of UVE common stock on 11/25/2025. The sale was executed at a weighted average price of $33.456 per share, with individual trade prices ranging from $33.19 to $33.82.
Following this transaction, he beneficially owns 1,263,512 shares directly, plus 2,000 shares held indirectly through his spouse and 18,000 shares held indirectly through his children. The filing notes that detailed trade breakdowns by price within the reported range are available upon request.
UVE has a Rule 144 notice covering the planned sale of 20,000 shares of common stock. The shares are to be sold through Raymond James & Associates on the NYSE, with an approximate sale date of 11/25/2025 and an aggregate market value of 678,800.00. The seller acquired 20,000 common shares on 11/06/2025 from the issuer as "Lieu Compensation," with cash listed as the nature of payment on the same date. Over the past three months, the same seller completed two additional sales of 20,000 common shares each, on 09/04/2025 and 10/29/2025, for gross proceeds of 505,958.05 and 627,062.05, respectively.
Universal Insurance Holdings, Inc. (UVE) director reported an open‑market sale of company stock. On 11/14/2025, the reporting person sold 24,308 shares of UVE common stock at a weighted average price of $34.5076 per share, with individual trade prices ranging from $34.03 to $34.83. After this transaction, the director beneficially owns 247,320 shares of UVE common stock held directly.
Universal Insurance Holdings (UVE): Form 144 notice of proposed sale. A holder filed to sell 24,308 common shares, with an aggregate market value of $839,598.32. The filing lists Raymond James & Associates as broker and indicates an approximate sale date of 11/14/2025 on the NYSE.
The shares listed for sale were acquired in lieu of compensation on two dates: 7,298 shares on 01/13/2020 and 17,010 shares on 01/22/2018. As context, 28,286,229 shares were outstanding at the time shown in the notice; this is a baseline figure, not the amount being offered. The filing also reports a recent sale activity: Jon Springer sold 35,435 common shares on 10/30/2025 for $1,111,302.98.
Universal Insurance Holdings (UVE) received a Schedule 13G from Donald Smith & Co., Inc. reporting beneficial ownership of 1,494,895 common shares, equal to 5.28%.
Donald Smith & Co. reports sole voting power over 1,370,582 shares and sole dispositive power over 1,480,322 shares; DSCO Value Fund, L.P. holds 14,573 shares with sole voting and dispositive power. The filing states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control. The date of event which requires filing is 09/30/2025.
Universal Insurance Holdings (UVE) declared a cash dividend of $0.29 per share, consisting of a regular quarterly dividend of $0.16 and a special dividend of $0.13. The dividend is payable on December 12, 2025 to shareholders of record as of December 5, 2025.
This brings total regular and special dividends declared in 2025 to $0.77 per share. The mix of a recurring quarterly dividend plus a special payout signals an additional return to shareholders beyond the regular distribution for the year.
Universal Insurance Holdings (UVE): insider transaction reported. Executive Chairman and Director Sean P. Downes sold 20,000 shares of common stock on 10/29/2025 at a weighted average price of $31.4034. The sale occurred in multiple trades within a price range of $30.84 to $31.71.
Following this transaction, Downes beneficially owns 1,283,512 shares directly. He also reports indirect holdings of 18,000 shares by children and 2,000 shares by spouse.
Universal Insurance Holdings (UVE) — insider transaction filed. A company director reported a sale of common stock on 10/30/2025. The filing shows a disposition of 35,435 shares coded “S” for sale at a weighted average price of $31.4119.
Following the transaction, the reporting person beneficially owns 271,628 shares, held directly. The shares were sold in multiple trades within a price range of $31.13 to $31.625, and detailed trade‑by‑trade information is available upon request as noted in the footnote.
Universal Insurance Holdings (UVE) reported a profitable Q3 2025, with net income of $39.8 million after a loss in the prior year. Total revenues were $401.0 million as net premiums earned rose and losses and loss adjustment expenses fell to $252.3 million from $317.0 million a year ago. Diluted EPS was $1.38 (basic $1.43).
For the nine months, revenues reached $1.196 billion and net income was $116.4 million, reflecting stronger underwriting results and higher investment income. The balance sheet strengthened: stockholders’ equity increased to $495.0 million, cash and cash equivalents rose to $405.1 million, and restricted cash was $69.1 million. Unpaid losses declined to $682.6 million, aided by settlement of prior catastrophe claims. The company paid a $0.16 quarterly common dividend and continued share repurchases while maintaining $100.0 million of senior notes due 2026 and an undrawn $50.0 million revolving credit line. Shares outstanding were 28,048,881 as of October 27, 2025.